Blog

- NOVEL DISCOVERIES

Monteris Medical Announces New Study Showing NeuroBlate® Laser Ablation May Enhance Immunotherapy Response, Providing Significant Overall Survival Improvement in Recurrent High Grade Brain Tumors

MINNETONKA, Minn., March 4, 2026 /PRNewswire/ — Monteris Medical, the leader in minimally invasive neurosurgical technology with its NeuroBlate® System, announced today that a newly published randomized prospective study in the distinguished journal Nature Communications suggests that laser interstitial thermal therapy (LITT) using NeuroBlate may enhance the effectiveness of the immunotherapy drug pembrolizumab (Keytruda®) for patients with recurrent high grade astrocytoma, including glioblastoma (GBM).

Read More »